Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 5/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.41 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.41 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 2/20 | 0.39 |
| ▸ | NR2E3 | Q9Y5X4 | 2/20 | 0.39 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7373034 | 1.00 | TSHR (0.50) | TSHRLMNAALDH1A1GLAKMT2A | |
| SCHEMBL18530674 | 0.85 | TSHR (0.50) | TSHRLMNAALDH1A1GLAKMT2A | |
| SCHEMBL6896564 | 0.85 | TSHR (0.50) | TSHRLMNAALDH1A1GLAKMT2A | |
| SCHEMBL5104542 | 0.85 | TSHR (0.50) | TSHRLMNAALDH1A1GLAKMT2A | |
| SCHEMBL31674323 | 0.85 | TSHR (0.54) | TSHRLMNAALDH1A1KMT2AEPHX2 | |
| SCHEMBL30510726 | 0.84 | TSHR (0.50) | TSHRLMNAALDH1A1GLAKMT2A | |
| SCHEMBL18593567 | 0.83 | TSHR (0.52) | TSHRLMNAALDH1A1GLAKMT2A | |
| SCHEMBL27967920 | 0.82 | TSHR (0.56) | TSHRLMNAALDH1A1GLAKMT2A | |
| SCHEMBL11026734 | 0.78 | LMNA (0.54) | TSHRLMNAALDH1A1KMT2AEPHX2 | |
| SCHEMBL4081536 | 0.78 | TSHR (0.48) | TSHRLMNAALDH1A1GLAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8394996-B2 | Method for producing aldehyde functional compounds | EVONIK DEGUSSA GMBH (DE) | 2013-03-12 | — | — | US | disclosed |
| US-20120022276-A1 | METHOD FOR PRODUCING ALDEHYDE FUNCTIONAL COMPOUNDS | EVONIK DEGUSSA GMBH (DE) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120022276-A1 | METHOD FOR PRODUCING ALDEHYDE FUNCTIONAL COMPOUNDS | FASN, ALDH2, ALOX12 | TSHR 4779/4885LMNA 1519/4885ALDH1A1 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.